Madison, WI, United States of America

Nicholas Caruccio

This inventor holds 10 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 7 EPO patents. Top assignees: Epicentre Technologies Corporation, Illumina Corporation. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicholas Caruccio. Retrieved from https://idiyas.com/inventor/nicholas-caruccio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 10 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.4

ph-index = 7

Forward Citations = 543(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: **Nicholas Caruccio: Innovator in Genetic Engineering and Molecular Biology**

Introduction

Nicholas Caruccio is a distinguished inventor based in Madison, WI, known for his substantial contributions to the fields of genetic engineering and molecular biology. With a portfolio of 10 patents, his innovative work has significantly advanced the methodologies used in nucleic acid modification and analysis.

Latest Patents

Among his latest patents are two groundbreaking inventions:

1. **Transposon End Compositions and Methods for Modifying Nucleic Acids** - This invention presents methods, compositions, and kits that utilize a transposase and a transposon end to generate extensive fragmentation and 5'-tagging of double-stranded target DNA in vitro. Notably, this method allows the generation of 5′- and 3′-tagged single-stranded DNA fragments without the need for PCR amplification. It is particularly useful for various applications, including metagenomic analysis, copy number variation analysis, and comparative genomic sequencing, facilitating advancements in next-generation sequencing technologies.

2. **Linking Sequence Reads Using Paired Code Tags** - This patent involves artificial transposon sequences equipped with code tags designed for use with target nucleic acids. The methods developed aim to create artificial transposons, leveraging their properties to enhance the analysis of target nucleic acids, thereby improving research methodologies in genetic studies.

Career Highlights

Throughout his career, Nicholas Caruccio has worked with prominent companies in the biotechnology sector, including Epicentre Technologies Corporation and Illumina Corporation. His experience at these industry-leading organizations has contributed to his extensive knowledge and creativity in developing innovative solutions within genetic research.

Collaborations

Nicholas has collaborated with notable peers, including Haiying Li Grunenwald and Jerome J. Jendrisak. These collaborations have enabled him to broaden the scope of his inventions and impact the scientific community effectively.

Conclusion

With his remarkable body of work and innovative approach to genetic engineering, Nicholas Caruccio has established himself as a key figure in molecular biology. His revolutionary patents continue to shape the landscape of genetic research, contributing valuable tools and techniques that drive forward the boundaries of scientific discovery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…